From: Obesity as a mortality risk factor in the medical ward: a case control study
Entire Cohort (n = 179,288) | pre-COVID-19 (n = 149,098, 83.2%) | during-COVID-19 (n = 30,190, 16.8%) | P value | |
---|---|---|---|---|
BMI groups | ||||
< 18.5 kg/m2, N. (%) | 10,775 (6.0) | 8950 (6.0) | 1825 (6.0) | < 0.001 |
18.5–24.9 kg/m2, N. (%) | 64,757 (36.1) | 54,225 (36.4) | 10,532 (34.9) | < 0.001 |
25–29.9 kg/m2, N. (%) | 52,436 (29.2) | 43,426 (29.1) | 9010 (29.8) | < 0.001 |
30–34.9 kg/m2, N. (%) | 27,576 (15.4) | 22,813 (15.3) | 4763 (15.8) | < 0.001 |
35–39.9 kg/m2, N. (%) | 12,742 (7.1) | 10,500 (7.0) | 2242 (7.4) | < 0.001 |
≥ 40 kg/m2, N. (%) | 11,002 (6.1) | 9184 (6.2) | 1818 (6.0) | < 0.001 |
Demographics | ||||
Age, median (IQR), y | 65.0 (51.0–78.0) | 65.0 (51.0–78.0) | 66.0 (53.0–78.0) | < 0.001 |
Female, N. (%) | 91,308 (50.9) | 76,785 (51.5) | 14,523 (48.1) | < 0.001 |
Black, N. (%) | 48,515 (27.1) | 39,362 (26.4) | 9153 (30.3) | < 0.001 |
White, N. (%) | 57,700 (32.2) | 48,241 (32.4) | 9459 (31.3) | < 0.001 |
Comorbidities | ||||
CAD, N. (%) | 44,505 (24.8) | 35,740 (24.0) | 8765 (29.0) | < 0.001 |
CHF, N. (%) | 40,546 (22.6) | 32,995 (22.1) | 7551 (25.0) | < 0.001 |
DM, N. (%) | 66,022 (36.8) | 53,796 (36.1) | 12,226 (40.5) | < 0.001 |
HTN, N. (%) | 92,294 (51.5) | 74,896 (50.2) | 17,398 (57.6) | < 0.001 |
CKD, N. (%) | 33,031 (18.4) | 27,150 (18.2) | 5881 (19.5) | < 0.001 |
COPD, N. (%) | 24,788 (13.8) | 20,613 (13.8) | 4175 (13.8) | 0.99 |
Cancer, N. (%) | 51,659 (28.8) | 42,591 (28.6) | 9068 (30.0) | < 0.001 |
Past or present smoking, N. (%) | 75,186 (41.9) | 63,967 (42.9) | 11,219 (37.2) | < 0.001 |
Mortality | ||||
Mortality rate, N. (%) | 4200 (2.3) | 3210 (2.2) | 990 (3.3) | < 0.001 |